科技最前线

 

Am J Cardiol

急性心肌梗死患者低密度脂蛋白胆固醇越低,越不容易发生院内死亡

晋川


众所周知,血脂代谢紊乱是急性心肌梗死(AMI)的危险因子,特别是低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)。随着LDL-C水平的增高,患者将来发生AMI的风险也随之增高。与LDL-C不同的是,HDL-C则是AMI的保护因子,表现为HDL-C水平越高,患者越不容易发生AMI。然而,在AMI发生与发展的过程中,LDL-C和HDL-C除了作为危险(保护)因子外,是否还可以作为预后因子呢?

近期Am J Cardiol在线刊登的一篇论文指出,LDL-C与AMI患者院内死亡密切相关。研究者对美国国家心肌梗死登记中心(National Registry of Myocardial Infarction,NRMI)的数据库进行了分析,采用多元logistic回归评价了115492名AMI患者就诊24小时内的血脂水平与院内死亡的关系。研究人员发现:LDL-C水平越高,患者发生院内死亡的风险越小。多变量的logistic回归结果表明:与LDL-C小于77 mg/dl的患者相比,LDL-C大于128 mg/dl的患者发生院内死亡的优势比(OR)为0.85(95%CI: 0.76-0.96)。最重要的是,LDL-C与AMI患者院内死亡的关联性与患者发病前是否接受降脂药物治疗无关,即不论患者入院前是否接受过降脂药物治疗,LDL-C增高均与院内死亡风险降低有关。相比之下,HDL-C与患者院内死亡的关系并不十分明显。

研究者指出,在AMI发生与发展的过程中,患者可能发生继发性肝脏功能衰竭,LDL-C的合成能力随之降低。因此,LDL-C的水平在一定程度上反映了肝脏的受损程度,其水平越低,表明肝脏受损程度越严重,患者的预后也因此越差。该研究发现LDL-C与AMI患者的近期预后密切相关,提示在AMI的救治过程中,可以将LDL-C视为一个近期预后判断指标。

原文信息
Relation between Serum Low-Density-Lipoprotein Cholesterol and In-Hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox)
The American Journal of Cardiology,2015: in press
Lipoprotein levels are currently recognized as independent risk factors for long-term cardiovascular events after acute myocardial infarction (AMI). During the acute-phase reaction following AMI, previous studies have reported trends of decreased low-density lipoprotein cholesterol (LDL-C), increased triglycerides, and variable high-density lipoprotein cholesterol (HDL-C) levels, often proportional to the severity of myocardial necrosis. However, the association between LDL-C and HDL-C levels and in-hospital mortality has not been well established following AMI. The relationship between lipid levels and in-hospital all-cause mortality in 115,492 patients hospitalized for AMI (July 2002–December 2006), registered in the National Registry of Myocardial Infarction (NRMI) 4b–5, was evaluated using multivariable-adjusted logistic regression models. Mean LDL-C was 104 ± 38, HDL-C 41 ± 14 and triglycerides 143 ± 83 (mg/dl). Compared with the lowest quartile of LDL-C (< 77 mg/dl), the risk of in-hospital mortality in the 2nd– 4th quartiles was decreased (adjusted odds ratio [OR] = 0.79, 0.80 and 0.85, respectively). For HDL-C, only those in the lowest quartile (< 31 mg/dl) had higher risk of in-hospital mortality (OR = 1.20) compared with the highest quartile (≥ 47 mg/dl). Results from NRMI 4b−5 suggest a lipid paradox, with lower LDL-C levels associated with increased risk of in-hospital mortality, contrary to findings outside of the acute setting. Consistent with previous analyses, lowest HDL-C levels were associated with increased in-hospital mortality. In conclusion, further explorations of the relationship between very low levels of LDL-C, myocardial necrosis and subsequent adverse cardiovascular events are warranted.

原文链接:http://www.sciencedirect.com/science/article/pii/S0002914914022693


 

主办:医学研究与发表编辑部
赞助:美捷登生物科技有限公司

出版:华誉出版社有限公司

主编:夏华向
执行主编:张媛媛
编委会成员:段 柳 易 琴 李玉冰

网址:www.mrpcenter.com
电子信箱:sub.mrpexpress@gmail.com